You have 9 free searches left this month | to do more
Showing 1 - 25 of
607 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia Vera
Available
  • Polycythemia Vera
  • (no location specified)
2022-03-07
Mar 7, 2022
P
A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera
Recruiting
  • Polycythemia Vera
  • Plantation, Florida
  • +1 more
2022-03-15
Mar 15, 2022
P
Safety Evaluation Study for Patients With Polycythemia Vera
Recruiting
  • Polycythemia Vera
  • Hirakata, Osaka, Japan
  • +2 more
2022-02-08
Feb 8, 2022
U
Molecular Biology of Polycythemia and Thrombocytosis
Recruiting
  • Polycythemia
  • Thrombocytosis
    • Salt Lake City, Utah
      University of Utah
    2021-10-29
    Oct 29, 2021
    I
    A Study to Evaluate IONIS-TMPRSS6-LRx (ISIS 702843) in Patients With Polycythemia Vera
    Recruiting
    • Phlebotomy Dependent Polycythemia Vera
    • Whittier, California
    • +2 more
    2022-03-10
    Mar 10, 2022
    T
    IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV)
    Recruiting
    • Essential Thrombocythemia
    • Polycythemia Vera
    • Miami, Florida
      University of Miami
    2021-09-23
    Sep 23, 2021
    U
    CPAP in Treating Obstructive Sleep Apnea in Patients With Polycythemia Vera or Essential Thrombocythemia
    Recruiting
    • CALR Gene Mutation
    • +5 more
    • Continuous Positive Airway Pressure
    • +2 more
    • Salt Lake City, Utah
      Huntsman Cancer Institute/University of Utah
    2022-03-01
    Mar 1, 2022
    P
    PTG-300 in Patients With Polycythemia Vera and Elevated Hematocrit
    Active, not recruiting
    • Polycythemia Vera
    • Incheon, Korea, Republic of
    • +7 more
    2022-03-08
    Mar 8, 2022
    T
    Clinical Efficacy of Erythropheresis in High Altitude Polycythemia
    Recruiting
    • High Altitude Polycythemia
    • Erythropheresis
    • Shigatse, Tibet, China
      NO.953 Hospital
    2021-03-29
    Mar 29, 2021
    M
    Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate - 2013
    Completed
    Has Results
    • Chronic Myelomonocytic Leukemia
    • +4 more
    • Imatinib Mesylate (Gleevec)
    • Houston, Texas
      UT MD Anderson Cancer Center
    2021-12-07
    Dec 7, 2021
    P
    Extension Study After Completion of Phase 2 Study for P1101 With Polycythemia Vera (PV) Patients (Study A19-201)
    Recruiting
    • Polycythemia Vera (PV)
    • P1101 (Rropeginterferon alfa-2b)
    • Toon-shi, Ehime, Japan
    • +5 more
    2021-12-08
    Dec 8, 2021
    P
    Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply - 2021
    Completed
    • Polycythemia Vera (PV)
    • Toon-shi, Ehime, Japan
    • +7 more
    2021-12-08
    Dec 8, 2021
    V
    TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea
    Active, not recruiting
    • Myelofibrosis
    • Polycythemia Vera
    • Phoenix, Arizona
    • +4 more
    2021-03-11
    Mar 11, 2021
    N
    Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis
    Not yet recruiting
    • Primary Myelofibrosis
    • +2 more
    • (no location specified)
    2021-11-05
    Nov 5, 2021
    M
    LCL161 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis
    Active, not recruiting
    • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
    • +2 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    2021-11-08
    Nov 8, 2021
    H
    A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera - 2020
    Terminated
    Has Results
    • Polycythemia Vera
    • Phoenix, Arizona
    • +10 more
    2021-12-07
    Dec 7, 2021
    M
    Ruxolitinib in Thrombocythemia and Polycythemia Vera
    Not yet recruiting
    • Essential Thrombocythemia
    • Polycythemia Vera
    • Boston, Massachusetts
    • +2 more
    2020-11-24
    Nov 24, 2020
    U
    MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polcythemia Vera
    Recruiting
    • Polycythemia Vera
    • London, United Kingdom
    • +1 more
    2021-11-29
    Nov 29, 2021
    N
    MAP to Provide Access to Ruxolitinib, for Patients With PMF or PPV MF or PET-MF
    Available
    • Primary Myelofibrosis (PMF)
    • +2 more
    • (no location specified)
    2022-01-18
    Jan 18, 2022
    U
    An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms
    Active, not recruiting
    • Myeloproliferative Neoplasm
    • +4 more
    • Orange, California
      Chao Family Comprehensive Cancer Center, University of Californi
    2022-01-20
    Jan 20, 2022
    S
    Long-term Safety and Efficacy of Momelotinib in Subjects With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Polycythemia Vera or Essential Thrombocythemia - 2018
    Completed
    Has Results
    • Primary Myelofibrosis
    • +4 more
    • Scottsdale, Arizona
    • +21 more
    2021-01-18
    Jan 18, 2021
    P
    Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)
    Recruiting
    • Polycythemia Vera
    • Phoenix, Arizona
    • +23 more
    2022-01-10
    Jan 10, 2022
    U
    Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera - 2014
    Terminated
    Has Results
    • Polycythemia Vera
    • Oklahoma City, Oklahoma
      University of Oklahoma Health Sciences Center
    2020-08-07
    Aug 7, 2020
    M
    Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm
    Recruiting
    • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    2021-10-30
    Oct 30, 2021
    N
    A Study to Evaluate Safety and Efficacy of Panobinostat in Participants With Primary Myelofibrosis - 2011
    Terminated
    Has Results
    • Primary Myelofibrosis
    • +2 more
    • Scottsdale, Arizona
    • +8 more
    2021-07-09
    Jul 9, 2021